NCT03520452
Effect of Chlorogenic Acids on the Human Vasculature
Société des Produits Nestlé (SPN)·ClinicalTrials.gov·otherCompleted
View on ClinicalTrials.gov →Study focus
- Disease/Condition
- Endothelial Dysfunction
- Drug/Device/Intervention
- Green coffee extract
- Study type
- Interventional
- Intervention type
- other
Sponsor & location
- Primary sponsor
- Société des Produits Nestlé (SPN)
- Location
- Crawley, Australia
Timeline & enrollment
- Phase
- N/A
- Start date
- Mar 14, 2018
- End date
- Dec 20, 2018
- Enrollment
- 22 participants
Primary outcome
Efficacy by oral administration of chlorogenic acid in improving endothelial function
Summary
This study evaluates effects of different doses of chlorogenic acids on vascular health.
ICD-10 classifications
Other peripheral vascular diseasesAtherosclerosis of arteries of extremitiesOther specified peripheral vascular diseasesRenovascular hypertensionOther disorders of arteries and arterioles
Data source
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT03520452
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for NCT03520452 through Pure Global AI's free database. This phase not specified trial is sponsored by Société des Produits Nestlé (SPN) and is currently Completed. The study focuses on Endothelial Dysfunction. Target enrollment is 22 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.